Sunday, January 29, 2023
420 Daily Newz
  • Home
  • Popular Weed Strains
No Result
View All Result
  • Home
  • Popular Weed Strains
No Result
View All Result
420 Daily Newz
No Result
View All Result
Home 420 Daily Newz

Rat Study Examines Psilocybin as Treatment for Autism Spectrum Disorder

420 Daily Newz by 420 Daily Newz
December 15, 2022
in 420 Daily Newz
0
Rat Study Examines Psilocybin as Treatment for Autism Spectrum Disorder
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Little by little, researchers are exploring the effects of psilocybin on people living with autism spectrum disorder (ASD)—and the evidence showing the compound’s promise in treating the condition continues to grow.

There is no cure for ASD or similar conditions, so many families resort to behavioral therapies, with few other options on the table. But a rise in alternative therapies involving cannabis or psychedelics is forming, with notable promise from psilocybin.

A study published in the journal Psychopharmacology examined the effects of psilocybin microdoses on Fragile X syndrome (FXS)—a leading cause of autism. FXS is the most common form of inherited intellectual disability (ID) and the leading cause of ASD involving one gene. 

RelatedPosts

Lawmakers want a probe, hearings into California cannabis

Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

Researchers gave different doses of psilocybin to test rats and then tested their cognitive abilities. They examined cognitive deficits displayed by the recently validated Fmr1-Δexon 8 rat “model of ASD,” which is also a model of FXS, and how psilocybin plays a role. 

The study, “Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome,” examined rat microdoses of psilocybin for 5-14 day periods.

Serotonin insufficiencies during childhood may have an impact on brain patterning in neurodevelopmental disorders, manifesting as behavioral and emotional symptoms, researchers explained in the study. And since psilocybin stimulates serotonergic signaling, it may offer promise as effective early interventions for developmental disorders such as ASD and FXS.

Researchers first gave rats a single large dose of psilocybin and then tested any changes to their cognitive abilities, finding some improvements. Rats that did not have FXS led to reductions in cognitive performance. 

Researchers then gave another group of rats microdoses over the course of five days, giving them cognition tests daily. 

They observed improvements in all of the rats to the extent that their cognition results were nearly identical to rats that did not have FXS. Researchers ran the experiment again, extending it to two weeks, and they found identical results.

“Our results revealed that systemic and oral administration of psilocybin microdoses normalizes the aberrant cognitive performance displayed by adolescent […] rats in the short-term version of the novel object recognition test—a measure of exploratory behavior, perception, and recognition,” researchers wrote.

The data supports existing theories of how psilocybin may affect the production of serotonin and thus help people living with cognitive and emotional conditions.

“These data support the hypothesis that serotonin-modulating drugs such as psilocybin may be useful to ameliorate ASD-related cognitive deficits. Overall, this study provides evidence of the beneficial effects of different schedules of psilocybin treatment in mitigating the short-term cognitive deficit observed in a rat model of FXS.”

The goal is to eventually commence clinical trials of psilocybin on human patients. 

Researchers across the board are experimenting with psilocybin (as well as several cannabis compounds) to treat ASD and other autism-related conditions.

One Canadian research team has studies already underway. Dr. Max Jones and Dr. Gale Bozzo, two professors at University of Guelph’s Ontario Agricultural College (Department of Plant Agriculture), received a Health Canada “dealer’s license” on Oct. 25. The license permits the cultivation of psilocybin mushrooms, and is one of the first universities in Canada to be permitted to do so.

Dr. Melissa Perreault, Professor in Ontario Veterinary College’s Department of Biomedical Sciences, has experience and has previously involved studies of the molecular and cellular mechanisms associated with medical conditions like depression or ASD. Her plan is to examine the signaling pathways that psilocybin might affect.

More research is needed to determine psilocybin’s efficacy for the treatment of ASD in human trials.

Source link

Previous Post

Cory Booker Says Mitch McConnell Is Blocking Cannabis Bills

Next Post

New Frontier Data Explores How Packaging Affects Consumer Purchasing Habits

420 Daily Newz

420 Daily Newz

Next Post
New Frontier Data Explores How Packaging Affects Consumer Purchasing Habits

New Frontier Data Explores How Packaging Affects Consumer Purchasing Habits

  • Trending
  • Comments
  • Latest
D.C. Council Approves Bill Providing Workplace Protections For Marijuana Consumers

27 Websites That Will Teach You About Growing Cannabis

August 24, 2022
5 Ways To Get Weed Smell Out Of Your Car

5 Ways To Get Weed Smell Out Of Your Car

August 24, 2022
How to Become a Budtender

How to Become a Budtender

November 21, 2022
Can CBD Help With Memory?

Can CBD Help With Memory?

August 22, 2022
Brand Review: Thrive Flower CBD – Nature’s Wellness Solution

Brand Review: Thrive Flower CBD – Nature’s Wellness Solution

0

Strain Review: Cookies & Cream from My Weed Bunny

0
5 Reasons Californians Should Keep Buying Weed with a Medical Card

5 Reasons Californians Should Keep Buying Weed with a Medical Card

0

Cannabis and Rental Properties: How to Create a Marijuana-Friendly Rental Property

0
Lawmakers want a probe, hearings into California cannabis

Lawmakers want a probe, hearings into California cannabis

January 29, 2023
Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

January 28, 2023
Using Mindfulness To Heal Body Image & Feel More Confident

Using Mindfulness To Heal Body Image & Feel More Confident

January 27, 2023
Encuesta Exclusiva: ¿En Qué Lugares No Da Fumar Porro? Encuesta Exclusiva: ¿En Qué Lugar NO te Fumarías un Porro y Por Qué?

Encuesta Exclusiva: ¿En Qué Lugares No Da Fumar Porro? Encuesta Exclusiva: ¿En Qué Lugar NO te Fumarías un Porro y Por Qué?

January 27, 2023
Lawmakers want a probe, hearings into California cannabis

Lawmakers want a probe, hearings into California cannabis

January 29, 2023
Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

January 28, 2023
Using Mindfulness To Heal Body Image & Feel More Confident

Using Mindfulness To Heal Body Image & Feel More Confident

January 27, 2023
Encuesta Exclusiva: ¿En Qué Lugares No Da Fumar Porro? Encuesta Exclusiva: ¿En Qué Lugar NO te Fumarías un Porro y Por Qué?

Encuesta Exclusiva: ¿En Qué Lugares No Da Fumar Porro? Encuesta Exclusiva: ¿En Qué Lugar NO te Fumarías un Porro y Por Qué?

January 27, 2023
Argentina Launches New Agency To Boost Cannabis Industry

Argentina Launches New Agency To Boost Cannabis Industry

January 27, 2023
Upstate New York Officials Clash Over New Cannabis Regulations

Upstate New York Officials Clash Over New Cannabis Regulations

January 27, 2023

Other 420 Daily Newz Related Sites:

High Yields

MJ News Daily

Recent News

Lawmakers want a probe, hearings into California cannabis

Lawmakers want a probe, hearings into California cannabis

January 29, 2023
Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

Cash Only’s 420 Recs: Tracie Morrissey, Internet Sleuth and ‘Pot Psychology’ Host

January 28, 2023
No Result
View All Result
  • Home
  • Popular Weed Strains

© 2021 MJ News Daily

testing 123